Literature DB >> 31914973

Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial.

Sanne Y Smith-Apeldoorn1, Jolien K E Veraart2,3, Jeanine Kamphuis2, Antoinette D I van Asselt4, Daan J Touw5, Marije Aan Het Rot6, Robert A Schoevers2.   

Abstract

After publication of our article [1] we were notified that Figure 1 was wrongly presented.

Entities:  

Year:  2020        PMID： 31914973      PMCID： PMC6947821          DOI： 10.1186/s12888-019-2398-7

Source DB:  PubMed          Journal:  BMC Psychiatry        ISSN： 1471-244X            Impact factor:   3.630


Correction to: BMC Psychiatry (2019) 19:375 https://doi.org/10.1186/s12888-019-2359-1 After publication of our article [1] we were notified that Fig. 1 was wrongly presented.
Fig. 1

Trial flowchart. Schematic overview of the study design. T: Number illustrates number of weeks after baseline

Trial flowchart. Schematic overview of the study design. T: Number illustrates number of weeks after baseline The correct figure and corresponding title is presented below: The original article has been corrected.
  1 in total

1.  Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial.

Authors:  Sanne Y Smith-Apeldoorn; Jolien K E Veraart; Jeanine Kamphuis; Antoinette D I van Asselt; Daan J Touw; Marije Aan Het Rot; Robert A Schoevers
Journal:  BMC Psychiatry       Date:  2019-11-29       Impact factor: 3.630
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.